Earnings Feed
Start Free
Home/Filings/4/0001415889-13-001969
4//SEC Filing

ACADIA PHARMACEUTICALS INC 4

Accession 0001415889-13-001969

$ACADCIK 0001070494operating
View on SEC.govCompany Profile

Filed

Oct 2, 8:00 PM ET

Accepted

Oct 3, 6:35 PM ET

Size

15.8 KB

Accession

0001415889-13-001969

Insider Transaction Report

Form 4
Period: 2013-10-01
ACADIA PHARMACEUTICALS INCACAD
Aasen Thomas H
Exec. VP, CFO & CBO
Transactions
  • Exercise/Conversion

    Common Stock

    2013-10-01$1.55/sh+17,500$27,125→ 54,085 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-10-01−5,000→ 26,000 total
    Exercise: $6.95Exp: 2015-03-10→ Common Stock (5,000 underlying)
  • Exercise/Conversion

    Common Stock

    2013-10-01$6.95/sh+5,000$34,750→ 36,585 total
  • Gift

    Common Stock

    2013-10-01−30,000→ 24,085 total
  • Gift

    Common Stock

    2013-10-01+30,000→ 30,000 total(indirect: By Trust)
  • Sale

    Common Stock

    2013-10-01$27.87/sh−30,000$836,121→ 0 total(indirect: By Trust)
  • Exercise/Conversion

    Stock Option (right to buy)

    2013-10-01−17,500→ 123,471 total
    Exercise: $1.55Exp: 2020-03-11→ Common Stock (17,500 underlying)
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
  • [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $27.75 to $28.00 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
  • [F3]25% of the shares subject to the Stock Option vested and became exercisable on March 11, 2006. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
  • [F4]25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.

Documents

1 file

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070494

Filing Metadata

Form type
4
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 6:35 PM ET
Size
15.8 KB
View on SEC.gov